Articolul precedent |
Articolul urmator |
361 2 |
Ultima descărcare din IBN: 2022-10-27 15:15 |
SM ISO690:2012 POPA, Vera, GROSU, Oxana, MANVELOV, Anastasia, CEBOTARI, Ecaterina. Neurological complications in patients with COVID-19 infections: results of energy study in the Republic of Moldova. In: Cercetarea în biomedicină și sănătate: calitate, excelență și performanță, Ed. 1, 20-22 octombrie 2021, Chişinău. Chișinău, Republica Moldova: 2021, p. 207. ISBN 978-9975-82-223-7 (PDF).. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Cercetarea în biomedicină și sănătate: calitate, excelență și performanță 2021 | |||||||
Conferința "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță" 1, Chişinău, Moldova, 20-22 octombrie 2021 | |||||||
|
|||||||
Pag. 207-207 | |||||||
|
|||||||
Descarcă PDF | |||||||
Rezumat | |||||||
Background. ENERGY registry developed by the European Academy of Neurology study neurological manifestations in patients with COVID-19 infection. Diomid Gherman Institute of Neurology and Neurosurgery join these efforts in December 2020. Objective of the study. The aim of the study was to present the Moldovan cohort of patients with COVID 19 infection and neurological manifestation registered in the ENERGY. Material and Methods. The registry record demographic data, comorbidities, complications, new neurological finds in confirmed COVID-19 patients during the consultation or hospital stay, and status at discharge appreciated with Rankin score. The patients were evaluated at 6 and 12 months by phone. Results. Moldovan cohort of patients with COVID 19 and neurologic manifestation by May 2021 consist of 168 patients (50,6% men and 49,4% women). New neurological findings in patients with COVID-19 infection were: Stroke (62,5%); Headache (48,2%); Cognitive impairment (35,7%); Vertigo(32,2%); Disexecutive sindrom (27,3%); Stupor/coma (22,1%); Hipoactive delirium/ acute encefalopathy (17,9%); Myalgia (11,3%); Hiperactive delirium (9,5%); Dysautonomia (9,5%); Ataxia (9,4%); Spinal cord disorder (7,2%); Peripheral neuropathy(5,4%); Sleep disturbances (4,8%). Mortality rate in the cohort was 22.61%. Conclusion. The most frequently neurological manifestation was stroke, cognitive impairment and headache. They have many comorbidities, history of neurological disease, complication during hospital stay and high mortality rate. |
|||||||
Cuvinte-cheie registry, neurological manifestations, energy, COVID 19, registru, manifestări neurologice, ENERGY, COVID-19 |
|||||||
|